StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New Auditors

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Dec 31, 2020 5:32pm

241 Views

Post# 32205868

RE:New Auditors

Why are we changing so many times, disputes on the numbers seem to be the issue, James needs to provide details. I think this is the third in the past 4 years. Now we can expect delays.

Happy New Years all.

Vazzman wrote:

StageZero Life Sciences, Ltd Announces Appointment of New Auditors
12/31/2020

TORONTO, ON / ACCESSWIRE / December 31,2020 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company") announced today that it has engaged Toronto based McGovern Hurley LLP as its auditors. BDO Canada LLP ("BDO") has resigned as the Company's auditors.

"We look forward to working with McGovern Hurley who specialize in public companies of similar size to StageZero; and we thank BDO for their work during 2020 which was a pivotal year for us." said James Howard-Tripp, Chairman and CEO of StageZero Life Sciences.

The Company will continue to work with MNP LLP, in assisting management, with the preparation of its financial statements.